Compare · OMCL vs XNDU
OMCL vs XNDU
Side-by-side comparison of Omnicell Inc. (OMCL) and Xanadu Quantum Technologies Limited (XNDU): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OMCL and XNDU operate in Computer Manufacturing (Technology), so they compete in similar markets.
- OMCL carries a market cap of $6.51B.
- Over the past year, OMCL is up 21.1% and XNDU is up 209.8% - XNDU leads by 188.6 points.
- XNDU has been more active in the news (10 items in the past 4 weeks vs 3 for OMCL).
- OMCL has more recent analyst coverage (24 ratings vs 2 for XNDU).
- Company
- Omnicell Inc.
- Xanadu Quantum Technologies Limited
- Price
- $37.35+2.78%
- $30.67+6.33%
- Market cap
- $6.51B
- -
- 1M return
- +6.90%
- +238.52%
- 1Y return
- +21.15%
- +209.80%
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- News (4w)
- 3
- 10
- Recent ratings
- 24
- 2
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest OMCL
- Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026
- SEC Form DEF 14A filed by Omnicell Inc.
- AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
- SEC Form 4 filed by Njoku Nnamdi
- SEC Form 4 filed by Manley Corey J
- SEC Form 4 filed by Nutt Brian H.
- SEC Form 4 filed by Radford Harlan Baird
- SEC Form 4 filed by Lipps Randall A
- SEC Form PRE 14A filed by Omnicell Inc.
- SEC Form SCHEDULE 13G filed by Omnicell Inc.
Latest XNDU
- SEC Form F-1 filed by Xanadu Quantum Technologies Limited
- Canaccord Genuity initiated coverage on Xanadu Quantum Technologies Inc. with a new price target
- Northland Capital initiated coverage on Xanadu Quantum Technologies Inc. with a new price target
- SEC Form 20-F filed by Xanadu Quantum Technologies Limited
- SEC Form 6-K filed by Xanadu Quantum Technologies Limited
- Xanadu Announces Fourth Quarter and Full Year 2025 Results
- SEC Form SCHEDULE 13G filed by Xanadu Quantum Technologies Limited
- SEC Form SCHEDULE 13D filed by Xanadu Quantum Technologies Limited
- SEC Form SCHEDULE 13G filed by Xanadu Quantum Technologies Limited
- SEC Form SCHEDULE 13G filed by Xanadu Quantum Technologies Limited